In a historic milestone, Prime Minister Narendra Modi unveiled NexCAR19, India’s first indigenous CAR-T Cell Therapy, at the Emerging Science, Technology & Innovation Conclave (ESTIC) 2025 in Delhi. It is developed by ImmunoACT, an IIT Bombay spin-off. It is supported by the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). NexCAR19 is the world’s first humanised CAR-T therapy, truly “Made in India, for the world.” CAR-T Cell Therapy is an immunotherapy that reprograms a patient’s immune cells to fight blood cancers like Acute Lymphocytic Leukemia (ALL).
This Question is Also Available in:
मराठीहिन्दीಕನ್ನಡ